NurExone Biologics: Promising Future in Regenerative Medicine

NurExone Biologics is developing exosome-based therapies for non-invasive treatment of central nervous system injuries, with their lead product, ExoPTEN, showing significant promise in preclinical trials. The company is expanding its research into optic nerve regeneration, with a study initiated by…